BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 15202161)

  • 1. Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient.
    Yetgin S; Cetin M; Ozyürek E; Aslan D; Uçkan D
    Pediatr Hematol Oncol; 2004; 21(3):223-6. PubMed ID: 15202161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
    Al-Abdwani RM; Khamis FA; Balkhair A; Sacharia M; Wali YA
    Pediatr Hematol Oncol; 2008 Sep; 25(7):699-703. PubMed ID: 18850484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT.
    Kaptan K; Beyan C; Ural AU; Ustün C; Cetin T; Avcu F; Kubar A; Aliş M; Yalçin A
    Am J Hematol; 2001 Aug; 67(4):252-5. PubMed ID: 11443638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature.
    Pardi DS; Romero Y; Mertz LE; Douglas DD
    Am J Gastroenterol; 1998 Mar; 93(3):468-70. PubMed ID: 9517662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19 induced transient aplastic crisis in an immunocompetent child.
    Agrawal M; Paul RT; Pamu P; Avmr N
    Turk Patoloji Derg; 2015; 31(2):158-60. PubMed ID: 24994616
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplastic crisis associated with parvovirus B19 in an adult with hereditary spherocytosis.
    Beland SS; Daniel GK; Menard JC; Miller NM
    J Ark Med Soc; 1997 Sep; 94(4):163-4. PubMed ID: 9308316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transient myelodysplasia associated with human parvovirus B19 infection in a child without underlying disease].
    Tezuka T; Sugita K; Sato H; Uno K; Yamakawa N; Goi K; Inukai T; Nakazawa S
    Rinsho Ketsueki; 2001 Nov; 42(11):1096-100. PubMed ID: 11808077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
    Bergen GA; Sakalosky PE; Sinnott JT
    J Heart Lung Transplant; 1996 Aug; 15(8):843-5. PubMed ID: 8878766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplastic crisis induced by human parvovirus B19 as an initial presentation of hereditary spherocytosis.
    Carzavec D; Gaćina P; Vasilj A; Katović SK
    Coll Antropol; 2010 Jun; 34(2):619-21. PubMed ID: 20698139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful bone marrow transplantation for severe aplastic anemia in a patient with persistent human parvovirus B19 infection.
    Goto H; Ishida A; Fujii H; Kuroki F; Takahashi H; Ikuta K; Kai S; Yokota S
    Int J Hematol; 2004 May; 79(4):384-6. PubMed ID: 15218970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital aplastic anemia caused by parvovirus B19 infection].
    Vepreková L; Jelínek J; Zeman J
    Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of the IRF: assessment of erythroid regeneration following parvo B19 infection.
    Wyrick-Glatzel J; Conway-Klaassen J
    Clin Lab Sci; 2002; 15(4):208-12. PubMed ID: 12776780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease.
    Osaki M; Matsubara K; Iwasaki T; Kurata T; Nigami H; Harigaya H; Baba K
    Ann Hematol; 1999 Feb; 78(2):83-6. PubMed ID: 10089023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.
    Oshima K; Kikuchi A; Mochizuki S; Arai T; Oishi T; Hanada R
    Pediatr Infect Dis J; 2008 Jul; 27(7):651-2. PubMed ID: 18520445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia.
    Yeh SP; Chiu CF; Lee CC; Peng CT; Kuan CY; Chow KC
    Br J Haematol; 2004 Aug; 126(3):428-33. PubMed ID: 15257717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
    Hayes-Lattin B; Seipel TJ; Gatter K; Heinrich MC; Maziarz RT
    Am J Hematol; 2004 Mar; 75(3):142-5. PubMed ID: 14978694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 infection among patients with chronic blood disorders.
    Badr MA
    Saudi Med J; 2002 Mar; 23(3):295-7. PubMed ID: 11938419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anaemia associated with parvovirus B19 infection.
    Qian XH; Zhang GC; Jiao XY; Zheng YJ; Cao YH; Xu DL; Chen CS
    Arch Dis Child; 2002 Nov; 87(5):436-7. PubMed ID: 12390927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.